Drug Profile
Research programme: anesthesia, chronic kidney disease and cancer therapeutics - Sphaera Pharma
Latest Information Update: 28 Mar 2020
Price :
$50
*
At a glance
- Originator Sphaera Pharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anaesthesia; Cancer; Kidney disorders
Most Recent Events
- 28 Mar 2020 No recent reports of development identified for research development in Anaesthesia in Singapore
- 28 Mar 2020 No recent reports of development identified for research development in Cancer in Singapore
- 28 Mar 2020 No recent reports of development identified for research development in Kidney-disorders in Singapore